主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ADMA
#1300
ADMA Biologics, Inc.
15.5
7
+5.49%
版块:
基础:
利润货币:
日范围
年范围
日变化
+5.49%
每月变动
-5.98%
6个月变化
-10.05%
年变化
+1.43%
前一天收盘价
14.7
6
Open
15.5
7
Bid
Ask
Low
15.5
7
High
15.5
7
交易量
204
市场
股票
医疗保健
ADMA
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
Alkermes Down Despite Q4 Earnings Beat, Announces Leadership Change
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues
ADMA Biologics Q4 每股收益 超出预期, 营收 低于预期
ADMA Biologics Inc earnings beat by $0.03, revenue fell short of estimates
ADMA Biologics即将公布财报:能否实现高目标?
Can OPKO Health's Pipeline Progress and Deals Drive Growth in 2026?
Adma Biologics总裁Adam Grossman出售价值337,679美元的股票
Adam Grossman, president of Adma Biologics, sells $337,679 in shares
Novocure Gains FDA Approval for Optune Pax to Treat Pancreatic Cancer
NeoGenomics Announces Launch of New Cancer Assay PanTracer Pro
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note